Premium
The clinical pharmacologist in drug regulation: a European perspective
Author(s) -
RAWLINS MICHAEL D.
Publication year - 1996
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1046/j.1365-2125.1996.03779.x
Subject(s) - clinical pharmacology , scrutiny , perspective (graphical) , pharmaceutical industry , medicine , engineering ethics , humility , pharmacology , product (mathematics) , medical education , political science , law , engineering , computer science , artificial intelligence , geometry , mathematics
1 The clinical pharmacologist in drug regulation has many roles to play. These include responsibilities for the premarketing assessment of a new product's efficacy and safety, for scrutiny of the summary of Product Characteristics, and for monitoring its performance after marketing. Furthermore, the clinical pharmacologist has a subsidiary responsibility in examining the results of preclinical pharmacological and toxicological studies. 2 Clinical pharmacologists in regulatory authorities have one further, and crucial, responsibility—humility. From their training and experience they will (or should) know of their own scientific limitations and of the necessity for seeking help and advice from other disciplines.